港股異動 | 中軟國際(0354.HK)漲超6% 獲瑞信看高股價至15.5港元
格隆匯6月18日丨華為鴻蒙概念股中軟國際(0354.HK)拉昇漲超6%,報13.36港元有望再度挑戰新高價,總市值達388億港元。今年華為終端設備將會全面升級到鴻蒙操作系統,預計到年底,整體規模將超過兩億。瑞信重申中軟國際“跑贏大市”評級,目標價上調27%至15.5港元,並調升對其2022-23年每股盈利預測2-4%,以反映更高的收入,主要是鴻蒙及數碼化趨勢下,由華為及其他大客户帶動。華為6月2日正式發佈鴻蒙系統,中軟國際持續大漲刷新歷史新高,近日回調後股價再度拉昇上揚。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.